Location: Phoenix
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Phoenix
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US020 · Incyte Corporation · NCT06959225To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Phase 3 · Biomed Testing Facility # BIO-01-85012 · Biomed Industries, Inc. · NCT06840496Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Phoenix Children's Hsptl · Novo Nordisk A/S · NCT06612268A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Phoenix Children's Hospital · New York Blood Center · NCT01656603Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in
Phase 2 · Ima Clinical Research Phoenix (Alea) /ID# 275737 · AbbVie · NCT06846320Mitral Valve Screening Survey
Phase N/A · Phoenix Cardiovascular Research Group · Medstar Health Research Institute · NCT04736667A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard
Phase N/A · Phoenix Childrens Hospital · Regeneron Pharmaceuticals · NCT06693531A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase 2 · Mountain West Derm - Blackhart PLLC dba Skin Cancer and Derm · Bluefin Biomedicine, Inc. · NCT07105488Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Cancer Center at Saint Joseph's · National Cancer Institute (NCI) · NCT05987241Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Phase 3 · Mayo Clinic Arizona · NX Development Corp · NCT05804370Infant Formula in Infants and Children With Cow's Milk Allergy
NA · Phoenix Children's · Abbott Nutrition · NCT06456541Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Mayo Clinic Hospital · Gilead Sciences · NCT05633654Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellit
NA · Arizona Kidney Disease and Hypertension Center · Well Cell Global · NCT07187479MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Banner Health Surgicenter · Stryker Instruments · NCT03072927RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Th
Phase N/A · Physicians Research Group, LLC · Boston Scientific Corporation · NCT01719055A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · Pulmonary Associates, PA · Pfizer · NCT07363694Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial
NA · Banner University Medical Center Phoenix · University of Arizona · NCT06931821Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · Mayo Clinic Hospital in Arizona · NRG Oncology · NCT04804644A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Mayo Clinic Arizona · Hoffmann-La Roche · NCT04929223CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · Associated Retina Consultants - Phoenix · EyePoint Pharmaceuticals, Inc. · NCT07449923MSC EVs in Dystrophic Epidermolysis Bullosa
Phase 1/Phase 2 · Phoenix Children's Hospital · Aegle Therapeutics · NCT04173650A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell C
Phase 3 · Research Site · AstraZeneca · NCT06129864AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT05850234Registry of Arthrex Hand and Wrist Products
Phase N/A · MORE Foundation · Arthrex, Inc. · NCT05046600A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1044 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · Mayo Clinic in Arizona - Phoenix · Bristol-Myers Squibb · NCT07063745Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Site 130 · Yarrow Bioscience, Inc. · NCT07682896A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metasta
Phase 2 · Ohio State University-Telemedicine · Sameek Roychowdhury · NCT06906562
Look up another city
Look up another condition